The short version of peptide mapping fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-09 and is reviewed periodically as new material appears.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Southern Rhodesia was represented in the Dodecanese Campaign of September–November 1943 by the Long Range Desert Group, which was withdrawn from the North African front in March 1943. After retraining for mountain operations in Lebanon, the LRDG moved in late September to the Dodecanese island of Kalymnos, north-west of Kos and south-east of Leros, off the coast of south-west Turkey. In the fall-out from the Armistice of Cassibile between Italy and the Allies, which had been concluded in the first week of September, the Allies were attempting to capture the Dodecanese so the islands could be used as bases against the German-occupied Balkans. Most of the Italian forces had changed sides; the LRDG found itself in an infantry role, acting as a mobile reserve for Italian troops. The Germans swiftly mobilised to expel the Allied forces and launched heavy air assaults on Kos and Leros. Without fighter support, the islands' defence was soon precarious; the LRDG and the rest of the troops on Kalymnos were withdrawn to Leros on 4 October after the Germans won the Battle of Kos. German air assaults on Leros intensified during late October, and at dawn on 12 November 1943 the Germans attacked Leros by sea and air. During the ensuing Battle of Leros, the LRDG Rhodesians at Point 320, commanded by Rhodesian Captain J R Olivey, spiked their position's guns and withdrew before counter-attacking and retaking the point the next day. They held that position for three more days, during which they learned that the Germans were winning the battle.
== Structure == The duodenum and the jejunum are the first and second parts of the small intestine, respectively. The suspensory muscle of the duodenum marks their formal division. The suspensory muscle arises from the right crus of the diaphragm as it passes around the esophagus, continues as connective tissue around the stems of the celiac artery and superior mesenteric artery, passes behind the pancreas, and enters the upper part of the mesentery, inserting into the junction between the duodenum and jejunum, the duodenojejunal flexure. Here, the muscles are continuous with the muscular layers of the duodenum.
Many governments require food manufacturers to label the energy content of their products to help consumers control their energy intake. To facilitate evaluation by consumers, food energy values (and other nutritional properties) in package labels or tables are often quoted for convenient amounts of the food, rather than per gram or kilogram; such as in "calories per serving" or "kcal per 100 g", or "kJ per package". The units vary depending on country:
Sources: en.wikipedia.org
Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems. Guidelines recommend that it be used only after cognitive behavioral therapy for insomnia and after behavioral changes, such as sleep hygiene, have been tried. It decreases the time to sleep onset by about fifteen minutes and at larger doses helps people stay asleep longer. It is taken by mouth and is available as conventional tablets, extended-release tablets, or sublingual tablets. Common side effects include daytime sleepiness, headache, nausea, and diarrhea. More severe side effects include memory problems and hallucinations. While flumazenil, a GABAA receptor antagonist, can reverse zolpidem's effects, usually supportive care is all that is recommended in overdose. Zolpidem is a nonbenzodiazepine, or Z-drug, which acts as a sedative and hypnotic as a positive allosteric modulator at the GABAA receptor. It is an imidazopyridine and increases GABA effects in the central nervous system by binding to GABAA receptors at the same location as benzodiazepines. It generally has a half-life of two to three hours. This, however, is increased in those with liver problems. Zolpidem was approved for medical use in the United States in 1992. It became available as a generic medication in 2007. Zolpidem is a schedule IV controlled substance in the US under the Controlled Substances Act of 1970 (CSA). In 2023, it was the 54th most commonly prescribed medication in the United States, with more than 11 million prescriptions.
==== Astronomy ==== In astronomy, in situ measurement involves collecting data directly at or near a celestial object using spacecraft or instruments physically present at the location. For example, the Parker Solar Probe conducts in situ studies of the Sun's atmosphere, while the Cassini–Huygens mission similarly analyzed Saturn's magnetosphere. In situ formation refers to astronomical objects that formed at their current locations without significant migration. Some theories propose that planets, such as Earth, formed in their present orbits rather than moving from elsewhere. Star clusters may form within their host galaxy, rather than being accreted from external sources.
=== Liquid chromatography-mass spectrometry === Liquid chromatography-mass spectrometry (LC-MS) has the capability to analyze compounds that are polar and less volatile. Derivatization is not required for these analytes as it would be in GC-MS, which simplifies sample preparation. As an alternative to immunoassay screening which generally requires confirmation with another technique, LC-MS offers greater selectivity and sensitivity. This subsequently reduces the possibility of a false negative result that has been recorded in immunoassay drug screening with synthetic cathinones and cannabinoids. A disadvantage of LC-MS on comparison to other analytical techniques such as GC-MS, is the high instrumentation cost. However, recent advances in LC-MS have led to higher resolution and sensitivity which assists in the evaluation of spectra to identify forensic analytes.
The Golan Heights holds significance for Christians and has been a destination for pilgrims due to biblical accounts of Jesus's visitation. This includes Confession of Peter, which took place in the city of Banias (Caesarea Philippi at the time). Following the Roman Empire's recognition of Christianity, several churches and monasteries were built in the area, and numerous Christian archaeological sites remain in the Golan, such as the Kursi and Deir Qeruh, and several ruins in Banias. Christians inhabited most villages and towns mixed with Druze in the Golan, such as Jubata ez-Zeit, Zarura, 'Ayn Fit, Haspin, Fiq, Quneitra, Ain al-Shaara, Hinah, and Arnah, in addition to Majdal Shams and Ein Qiniyye, where Christians constituted two-thirds of the population in the 19th century. These Christians were divided into several denominations, including Greek Orthodox, Maronites, Roman Catholics, and Protestants. Some Druze communities were established in the Golan during the 17th and 18th centuries. During the French Mandate period, there was a significant migration of Christians from villages to the city of Quneitra, forming the second largest population group there after the Circassians. Majdal Shams played a significant role in the Great Syrian Revolt of 1925–1927. In October 1925, a few months after Syrian Druze had begun fighting French forces in the nearby province of Jabal al-Duruz, a group of the town's Druze residents looted local Christian property.
Sources: en.wikipedia.org
Baechu-kimchi (배추김치) spicy napa cabbage kimchi, made from whole cabbage leaves Baechu-geotjeori (배추겉절이) unfermented napa cabbage kimchi Bossam-kimchi (보쌈김치) wrapped kimchi Baek-kimchi (백김치) white kimchi, made without chili pepper Dongchimi (동치미) a non-spicy watery kimchi Nabak-kimchi (나박김치) a mildly spicy watery kimchi Chonggak-kimchi (총각김치) cubed chonggak "ponytail" radish, a popular spicy kimchi Kkakdugi (깍두기) spicy cubed Korean radish strongly-scented kimchi containing fermented shrimp Oi-sobagi (오이소박이) cucumber kimchi that can be stuffed with seafood and chili paste, and is a popular choice during the spring and summer seasons Pa-kimchi (파김치) spicy green onion kimchi Yeolmu-kimchi (열무김치) is also a popular choice during the spring and summer, and is made with yeolmu radishes, and does not necessarily have to be fermented. Gat-kimchi (갓김치), made with Indian mustard Yangbaechu-kimchi (양배추 김치) spicy cabbage kimchi, made from "headed" cabbage leaves (as opposed to napa cabbage) Kimchi from the northern parts of Korea tend to have less salt and red chili and usually do not include brined seafood for seasoning. Northern kimchi often has a watery consistency. Kimchi made in the southern parts of Korea, such as Jeolla Province and Gyeongsang Province, uses salt, chili peppers and myeolchijeot (멸치젓, brined anchovy allowed to ferment) or saeujeot (새우젓, brined shrimp allowed to ferment), myeolchiaekjeot (멸치액젓), anchovy fish sauce, kkanariaekjeot (까나리액젓), liquid anchovy jeot, similar to fish sauce used in Southeast Asia, but thicker.
On 16 December 1989, the Hungarian minority in Timișoara held a public protest in response to an attempt by the government to evict Hungarian Reformed church Pastor László Tőkés. In July of that year, in an interview with Hungarian television, Tőkés had criticised the regime's systematisation policy and complained that Romanians did not even know their human rights. As Tőkés described it later, the interview, which had been seen in the border areas and was then spread all over Romania, had "a shock effect upon the Romanians, the Securitate as well, on the people of Romania. [...] [I]t had an unexpected effect upon the public atmosphere in Romania." At the behest of the government, his bishop removed him from his post, thereby depriving him of the right to use the apartment to which he was entitled as a pastor, and assigned him to be a pastor in the countryside. For some time his parishioners gathered around his home to protect him from harassment and eviction. Many passersby spontaneously joined in. As it became clear that the crowd would not disperse, the mayor, Petre Moț, made remarks suggesting that he had overturned the decision to evict Tőkés. Meanwhile, the crowd had grown impatient and, when Moț declined to confirm his statement against the planned eviction in writing, the crowd started to chant anti-communist slogans. Subsequently, police and Securitate forces showed up at the scene. By 19:30 the protest had spread and the original cause became largely irrelevant.
== Strategies == Before designing a distribution system, the supplier needs to determine what distribution channel to achieve in broad terms. The approach to distributing products or services depends on a number of factors including the type of product, especially perishability; the market served; the geographic scope of operations and the firm's overall mission and vision. The process of setting out a broad statement of the aims and objectives of a distribution channel is a strategic level decision.
All surface ships, as well as surfaced submarines, are in a positively buoyant condition, weighing less than the volume of water they would displace if fully submerged. To submerge hydrostatically, a ship must have negative buoyancy, either by increasing its own weight or decreasing its displacement of water. To control their displacement and weight, submarines have ballast tanks, which can hold varying amounts of water and air. For general submersion or surfacing, submarines use the main ballast tanks (MBTs), which are ambient pressure tanks, filled with water to submerge or with air to surface. While submerged, MBTs generally remain flooded, which simplifies their design, and on many submarines, these tanks are a section of the space between the light hull and the pressure hull. For more precise control of depth, submarines use smaller depth control tanks (DCTs)—also called hard tanks (due to their ability to withstand higher pressure) or trim tanks. These are variable buoyancy pressure vessels, a type of buoyancy control device. The amount of water in depth control tanks can be adjusted to hydrostatically change depth or to maintain a constant depth as outside conditions (mainly water density) change. Depth control tanks may be located either near the submarine's center of gravity, to minimise the effect on trim, or separated along the length of the hull so they can also be used to adjust static trim by transfer of water between them.
== Precautions == Protactinium is both toxic and highly radioactive; thus, it is handled exclusively in a sealed glove box. Its major isotope 231Pa has a specific activity of 0.048 curies (1.8 GBq) per gram and primarily emits alpha particles, which can be stopped by a thin layer of any material. However, it slowly decays into 227Ac, and then follows the more rapid actinium series, making its total activity (alpha, beta, and gamma) greater than one would calculate from that figure. As protactinium is present in small amounts in most natural products and materials, it is ingested with food or water and inhaled with air. Only about 0.05% of ingested protactinium is absorbed into the blood and the remainder is excreted. From the blood, about 40% of the protactinium deposits in the bones, about 15% goes to the liver, 2% to the kidneys, and the rest leaves the body. The biological half-life of protactinium is about 50 years in the bones, whereas its biological half-life in other organs has a fast and slow component. For example, 70% of the protactinium in the liver has a biological half-life of 10 days, and the remaining 30% for 60 days. The corresponding values for kidneys are 20% (10 days) and 80% (60 days). In each affected organ, protactinium promotes cancer via its radioactivity. The maximum amount of Pa allowed in the human body is 0.03 μCi (1.1 kBq), which corresponds to 0.5 micrograms of 231Pa. The maximum allowed concentrations of 231Pa in the air in Germany is 3×10−4 Bq/m3.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.